Fundraising FoxFifty Years — 2025 Investments
8 investments dated 2025 · listed companies and verified rows first · show all
Deepcell uses artificial intelligence and high-resolution imaging to analyze cell morphology for biological research and discovery.
AI & Machine LearningBiotechDeep TechMedical DevicesSunnyvale, US
Mahdokht Masaeli(Executive Officer, Director, Promoter)Mahyar Salek(Executive Officer, Director, Promoter)inMaddison Masaeli(Founder)inEuan Ashley(Director, Promoter)
Co-investorsAndreessen HorowitzBow CapitalDCVC (Data Collective)Horizons VenturesLifeX VenturesManta Ray Ventures+3 more
eFlow extracts lithium from dilute brines in North America using direct lithium extraction technology, serving the clean energy and electric vehicle supply chain.
CleantechEnergyNew MaterialsSan Bruno, US
Eric McShane(CEO and co-founder)Evan Gardner(CTO and co-founder)in
Co-investorsBlack FlagHarpoon VenturesStartXUnion Square Ventures (USV)Voyager Partners
Enoda develops synthetic cytokine receptors, called MIMICs, that link therapeutic "Signal 3" cytokine functions to controllable inputs to engineer cell therapies without systemic toxicity.
BiotechDeep TechLondon
Andrew John Scobie(Executive Officer, Director)Michael Chavez(Co-founder & CEO)inPaul B. Finn(Founder)inJennifer Urquhart(Executive Officer, Director)inJacqueline Elizabeth Porch(Executive Officer, Director)Lindsay James Whitelaw(Executive Officer, Director)
Co-investorsAIR CapitalMBX Capital
OnePot is a tool for synthesizing molecules, with end-to-end encryption of users' molecular structures.
AI & Machine LearningBiotechDeep Tech
Co-investorsNorrsken VCScript CapitalKhosla VenturesSpeedinvest
Red Queen Bio builds an AI-powered biodefense system that rapidly designs and manufactures countermeasures against emerging biological threats, enabling faster defensive responses to evolving pathogenic risks.
AI & Machine LearningBiotechDefense Tech
Hannu Rajaniemi(Founder)inNikolai Eroshenko(Founder)in
Co-investorsCompoundLongeVCOK ComputerThe Venture CollectiveCerberus VenturesHalcyon Futures Investments+1 more
Sift Biosciences develops T-cell immunotherapies for cancer and autoimmune diseases, using an AI-driven discovery platform combined with metagenomics and high-throughput cellular screening to identify microbially derived molecules that activate memory T cells.
AI & Machine LearningBiotechHealthtechSan Carlos, US
Yue Clare Lou(Co-Founder & CEO)in
BoardKevin Barrett(Director)inAltar Munis(Director)
Co-investorsEisai Innovation, Inc.SBI HoldingsFREEFLOWLifespan Vision Ventures
Vercept built AI software that runs locally on personal computers to understand user screens and workflows, enabling direct interaction with user intent.
AI & Machine LearningDeveloper Tools
Kiana Ehsani(Founder)inLuca Weihs(Founder)inRoss Girshick(Founder)Matt Deitke(Founder)Oren Etzioni(Founder)
Co-investorsAllen Institute for AI (AI2) IncubatorAllen Institute for Artificial Intelligence Incubator (AI2)Madrona Venture GroupPoint Nine
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Blueprint Bryan Johnson
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.